CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: berberine alkaloid
Accession: CHEBI:22754
browse the term
Synonyms: related_synonym: berberine alkaloids; berberines
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
ISO
berberine increases expression of abca1 protein in mouse liver and human hepatocytes
RGD
PMID:29505790
RGD:19165131
NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
EXP
Berberine results in increased expression of ABCB1A mRNA
CTD
PMID:20410605
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
increases expression
EXP
Berberine results in increased expression of ABCB1B mRNA
CTD
PMID:20410605
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Acadm
acyl-CoA dehydrogenase medium chain
multiple interactions
ISO
Berberine inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA]
CTD
PMID:25455889
NCBI chr 2:260,124,418...260,148,589
Ensembl chr 2:260,124,418...260,148,589
G
Acan
aggrecan
decreases expression
ISO
Berberine results in decreased expression of ACAN mRNA
CTD
PMID:26478571
NCBI chr 1:140,762,758...140,824,441
Ensembl chr 1:140,762,758...140,824,441
G
Ache
acetylcholinesterase
multiple interactions
EXP
Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased activity of ACHE protein]; Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased expression of ACHE mRNA]
CTD
PMID:29170048
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
G
Acox1
acyl-CoA oxidase 1
multiple interactions
ISO
Berberine inhibits the reaction [Ethanol results in decreased expression of ACOX1 mRNA]
CTD
PMID:25455889
NCBI chr10:104,724,534...104,748,003
Ensembl chr10:104,722,958...104,748,050
G
Acta2
actin alpha 2, smooth muscle
decreases expression
EXP
Berberine results in decreased expression of ACTA2 protein
CTD
PMID:17973934
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
Berberine inhibits the reaction [Clozapine results in increased expression of ADIPOQ mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of ADIPOQ mRNA]
CTD
PMID:20564506
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
G
Ahr
aryl hydrocarbon receptor
increases activity
EXP ISO
Berberine results in increased activity of AHR protein
CTD
PMID:16046213
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
G
Akt1
AKT serine/threonine kinase 1
multiple interactions increases phosphorylation
ISO EXP
Berberine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein] Berberine inhibits the reaction [Thioacetamide results in increased phosphorylation of AKT1 protein] Berberine results in increased phosphorylation of AKT1 protein
CTD
PMID:23954465 PMID:30138605
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Akt2
AKT serine/threonine kinase 2
multiple interactions
ISO
Berberine inhibits the reaction [Dexamethasone results in decreased expression of AKT2 mRNA]
CTD
PMID:20462044
NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
G
Alb
albumin
multiple interactions
EXP
Berberine inhibits the reaction [Thioacetamide results in decreased expression of ALB protein]
CTD
PMID:30138605
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
G
App
amyloid beta precursor protein
multiple interactions
EXP
Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased expression of APP mRNA]
CTD
PMID:29170048
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
G
Aurkb
aurora kinase B
decreases expression
ISO
Berberine results in decreased expression of AURKB mRNA
CTD
PMID:27311644
NCBI chr10:55,625,860...55,632,399
Ensembl chr10:55,626,741...55,634,991
G
Aurkc
aurora kinase C
increases expression
ISO
Berberine results in increased expression of AURKC mRNA
CTD
PMID:27311644
NCBI chr 1:69,958,452...69,964,546
Ensembl chr 1:69,958,452...69,963,592
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
EXP ISO
[Berberine co-treated with Thioacetamide] results in increased expression of BAX mRNA; Berberine inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein] Berberine results in increased expression of BAX mRNA; Berberine results in increased expression of BAX protein [Berberine co-treated with Niacinamide] results in increased expression of BAX protein; SRT1720 inhibits the reaction [Berberine results in increased expression of BAX protein]
CTD
PMID:16505103 PMID:20656010 PMID:25600690 PMID:26712469 PMID:30138605
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bbc3
Bcl-2 binding component 3
increases expression multiple interactions
ISO
Berberine results in increased expression of BBC3 mRNA [Berberine co-treated with Niacinamide] results in increased expression of BBC3 mRNA
CTD
PMID:26712469
NCBI chr 1:78,261,491...78,267,802
G
Bcl2
BCL2, apoptosis regulator
decreases expression increases expression multiple interactions
ISO EXP
Berberine results in decreased expression of BCL2 mRNA; Berberine results in decreased expression of BCL2 protein Berberine results in increased expression of BCL2 protein Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 protein]; Berberine inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA] [Berberine co-treated with Niacinamide] results in decreased expression of BCL2 protein; Berberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein]
CTD
PMID:16505103 PMID:20656010 PMID:23954465 PMID:24751971 PMID:25600690 PMID:26712469 PMID:30138605
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
Berberine results in decreased expression of BCL2L1 protein
CTD
PMID:16505103
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Bcl2l11
BCL2 like 11
multiple interactions increases expression
ISO
[Berberine co-treated with Niacinamide] results in increased expression of BCL2L11 mRNA Berberine results in increased expression of BCL2L11 mRNA
CTD
PMID:26712469
NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192
G
Bglap
bone gamma-carboxyglutamate protein
increases expression multiple interactions
ISO
Berberine results in increased expression of BGLAP mRNA; Berberine results in increased expression of BGLAP protein CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of BGLAP protein]; DKK1 protein inhibits the reaction [Berberine results in increased expression of BGLAP protein]
CTD
PMID:26478571
NCBI chr 2:187,741,770...187,748,445
Ensembl chr 2:187,741,770...187,742,747
G
Birc5
baculoviral IAP repeat-containing 5
affects binding
ISO
Berberine binds to BIRC5 promoter
CTD
PMID:17968851
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Casp3
caspase 3
multiple interactions increases cleavage increases activity increases expression
ISO EXP
[Berberine co-treated with Niacinamide] results in increased cleavage of CASP3 protein; Berberine results in increased cleavage of and results in increased activity of CASP3 protein Berberine results in increased cleavage of CASP3 protein [Berberine co-treated with Thioacetamide] results in increased expression of CASP3 mRNA; Berberine inhibits the reaction [Mercuric Chloride results in increased activity of CASP3 protein] Berberine results in increased activity of CASP3 protein Berberine results in increased expression of CASP3 mRNA
CTD
PMID:16505103 PMID:20656010 PMID:25600690 PMID:26712469 PMID:30138605
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp8
caspase 8
increases activity
ISO
Berberine results in increased activity of CASP8 protein
CTD
PMID:20656010
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Casp9
caspase 9
increases cleavage multiple interactions
ISO EXP
Berberine results in increased cleavage of CASP9 protein [Berberine co-treated with Thioacetamide] results in increased expression of CASP9 mRNA [Berberine co-treated with Niacinamide] results in increased cleavage of CASP9 protein
CTD
PMID:16505103 PMID:26712469 PMID:30138605
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
G
Cat
catalase
multiple interactions
EXP
Berberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the activity of CAT protein]; Berberine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Berberine inhibits the reaction [Thioacetamide results in decreased activity of CAT protein]
CTD
PMID:20828602 PMID:24751971 PMID:25600690 PMID:30138605
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
Berberine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Berberine inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; Berberine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; Berberine inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]
CTD
PMID:16391493
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccnd1
cyclin D1
decreases expression
ISO
Berberine results in decreased expression of CCND1 protein
CTD
PMID:16505103
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccnd2
cyclin D2
decreases expression
ISO
Berberine results in decreased expression of CCND2 protein
CTD
PMID:16505103
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
G
Ccne1
cyclin E1
decreases expression
ISO
Berberine results in decreased expression of CCNE1 protein
CTD
PMID:16505103
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
G
Ccnt1
cyclin T1
multiple interactions
EXP
Berberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]; Berberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]
CTD
PMID:20828602
NCBI chr 7:140,215,052...140,245,958
Ensembl chr 7:140,219,551...140,245,723
G
Cd36
CD36 molecule
increases expression multiple interactions
ISO
Berberine results in increased expression of CD36 mRNA Berberine results in increased expression of CD36 mRNA; Berberine results in increased expression of CD36 protein 15-deoxyprostaglandin J2 promotes the reaction [Berberine results in increased expression of CD36 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Berberine results in increased expression of CD36 protein]; Berberine promotes the reaction [15-deoxyprostaglandin J2 results in increased expression of CD36 mRNA]; Berberine results in increased expression of and affects the localization of CD36 protein; CEBPB protein promotes the reaction [Berberine results in increased expression of CD36 mRNA]
CTD
PMID:28038998 PMID:29408570
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
G
Cdh2
cadherin 2
decreases expression
ISO
Berberine results in decreased expression of CDH2 mRNA
CTD
PMID:26478571
NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Berberine results in decreased expression of CDK2 protein
CTD
PMID:16505103
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Berberine results in decreased expression of CDK4 protein
CTD
PMID:16505103
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
Berberine results in decreased expression of CDK6 protein
CTD
PMID:16505103
NCBI chr 4:27,781,728...27,969,653
Ensembl chr 4:27,785,647...27,966,398
G
Cdk9
cyclin-dependent kinase 9
multiple interactions
EXP
Berberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CDK9 mRNA]; Berberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CDK9 protein]
CTD
PMID:20828602
NCBI chr 3:11,742,269...11,747,117
Ensembl chr 3:11,742,266...11,747,113
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Berberine results in increased expression of CDKN1A protein
CTD
PMID:16505103 PMID:23747414
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
Berberine results in increased expression of CDKN1B protein
CTD
PMID:16505103
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
increases expression
ISO
Berberine results in increased expression of CDKN1C mRNA
CTD
PMID:26478571
NCBI chr 1:216,661,067...216,663,791
Ensembl chr 1:216,661,080...216,663,721
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions decreases expression
ISO
Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA]; Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA protein]; Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA protein] Berberine results in decreased expression of CEBPA mRNA
CTD
PMID:20564506 PMID:26478571
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
G
Cebpb
CCAAT/enhancer binding protein beta
affects phosphorylation multiple interactions increases expression
ISO
Berberine affects the phosphorylation of CEBPB protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Berberine results in increased phosphorylation of CEBPB protein]; CEBPB protein promotes the reaction [Berberine results in increased expression of CD36 mRNA] Berberine results in increased expression of CEBPB mRNA
CTD
PMID:28038998
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
G
Chek1
checkpoint kinase 1
increases expression
ISO
Berberine results in increased expression of CHEK1 protein modified form
CTD
PMID:23747414
NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
G
Chek2
checkpoint kinase 2
increases expression
ISO
Berberine results in increased expression of CHEK2 protein modified form
CTD
PMID:23747414
NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
G
Col10a1
collagen type X alpha 1 chain
increases expression
ISO
Berberine results in increased expression of COL10A1 mRNA
CTD
PMID:26478571
NCBI chr20:41,180,295...41,190,664
Ensembl chr20:41,184,287...41,189,633
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Berberine results in increased expression of COL1A1 mRNA
CTD
PMID:26478571
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
G
Col2a1
collagen type II alpha 1 chain
decreases expression
ISO
Berberine results in decreased expression of COL2A1 mRNA
CTD
PMID:26478571
NCBI chr 7:139,454,945...139,484,403
Ensembl chr 7:139,455,242...139,483,997
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
ISO
Berberine inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]
CTD
PMID:25455889
NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
G
Crebbp
CREB binding protein
increases expression
ISO
Berberine results in increased expression of CREBBP mRNA
CTD
PMID:27311644
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
G
Ctnnb1
catenin beta 1
increases expression multiple interactions
ISO
Berberine results in increased expression of CTNNB1 protein CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of BGLAP protein]; CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of RUNX2 mRNA]; CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of SPP1 protein]; DKK1 protein inhibits the reaction [Berberine results in increased expression of CTNNB1 protein]
CTD
PMID:26478571
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Cycs
cytochrome c, somatic
affects localization
ISO
Berberine affects the localization of CYCS protein
CTD
PMID:16505103
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
multiple interactions
ISO
Berberine inhibits the reaction [Dexamethasone results in increased expression of CYP17A1 mRNA]
CTD
PMID:20462044
NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity increases expression multiple interactions
ISO EXP
Berberine results in decreased activity of CYP1A1 protein Berberine results in increased expression of CYP1A1 mRNA Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]
CTD
PMID:16046213 PMID:22342832 PMID:24583342
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA]
CTD
PMID:22342832
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Streptozocin results in increased expression of CYP2B10 mRNA]; Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] Berberine results in increased expression of CYP2B10 mRNA
CTD
PMID:22342832
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions increases expression
ISO
Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B9 mRNA]; Berberine promotes the reaction [Streptozocin results in increased expression of CYP2B9 mRNA] Berberine results in increased expression of CYP2B9 mRNA
CTD
PMID:22342832
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression multiple interactions
ISO
Berberine results in decreased expression of CYP2E1 mRNA Berberine inhibits the reaction [Ethanol results in increased expression of CYP2E1 protein]; Berberine inhibits the reaction [Isoniazid results in increased expression of CYP2E1 mRNA]
CTD
PMID:22342832 PMID:25455889
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
decreases activity multiple interactions decreases expression
EXP ISO
Berberine results in decreased activity of CYP3A4 protein Atorvastatin promotes the reaction [Berberine results in decreased activity of CYP3A4 protein]; Berberine promotes the reaction [Atorvastatin results in decreased activity of CYP3A4 protein]; Berberine promotes the reaction [Atorvastatin results in decreased expression of CYP3A4 mRNA]; Berberine promotes the reaction [Atorvastatin results in decreased expression of CYP3A4 protein]; Berberine promotes the reaction [Simvastatin results in decreased activity of CYP3A4 protein]; Berberine promotes the reaction [Simvastatin results in decreased expression of CYP3A4 protein]; Simvastatin promotes the reaction [Berberine results in decreased activity of CYP3A4 protein] [Berberine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA Berberine results in decreased expression of CYP3A4 mRNA; Berberine results in decreased expression of CYP3A4 protein
CTD
PMID:21524698 PMID:30086269
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
multiple interactions
ISO
DKK1 protein inhibits the reaction [Berberine results in increased expression of BGLAP protein]; DKK1 protein inhibits the reaction [Berberine results in increased expression of CTNNB1 protein]; DKK1 protein inhibits the reaction [Berberine results in increased expression of RUNX2 mRNA]; DKK1 protein inhibits the reaction [Berberine results in increased expression of SPP1 protein]
CTD
PMID:26478571
NCBI chr 1:248,952,896...248,956,579
Ensembl chr 1:248,895,738...248,898,607 Ensembl chr 1:248,895,738...248,898,607
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
Berberine results in decreased expression of DNMT1 mRNA
CTD
PMID:27311644
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
G
Dnmt3b
DNA methyltransferase 3 beta
decreases expression
ISO
Berberine results in decreased expression of DNMT3B mRNA
CTD
PMID:27311644
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
Dzip3
DAZ interacting zinc finger protein 3
increases expression
ISO
Berberine results in increased expression of DZIP3 mRNA
CTD
PMID:27311644
NCBI chr11:54,404,777...54,475,361
Ensembl chr11:54,404,446...54,472,447
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
ISO
Berberine results in decreased phosphorylation of and results in increased expression of EIF4EBP1 protein
CTD
PMID:23363784
NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248
G
Ep300
E1A binding protein p300
increases expression
ISO
Berberine results in increased expression of EP300 mRNA
CTD
PMID:27311644
NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
G
Esr1
estrogen receptor 1
multiple interactions
ISO
Berberine inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
CTD
PMID:30818834
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Esrra
estrogen related receptor, alpha
multiple interactions
ISO
Berberine inhibits the reaction [XCT790 results in decreased activity of ESRRA protein]
CTD
PMID:30818834
NCBI chr 1:222,168,729...222,178,842
Ensembl chr 1:222,168,730...222,178,725
G
Fabp4
fatty acid binding protein 4
decreases expression multiple interactions increases expression
ISO
Berberine results in decreased expression of FABP4 mRNA 15-deoxyprostaglandin J2 promotes the reaction [Berberine results in increased expression of FABP4 mRNA]; Berberine promotes the reaction [15-deoxyprostaglandin J2 results in increased expression of FABP4 mRNA]
CTD
PMID:26478571 PMID:29408570
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
G
Fas
Fas cell surface death receptor
multiple interactions increases expression
ISO
[Clozapine co-treated with Berberine] results in decreased expression of FAS mRNA; Berberine inhibits the reaction [Risperidone results in increased expression of FAS mRNA] Berberine results in increased expression of FAS mRNA; Berberine results in increased expression of FAS protein
CTD
PMID:20564506 PMID:20656010
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Faslg
Fas ligand
increases expression
ISO
Berberine results in increased expression of FASLG mRNA; Berberine results in increased expression of FASLG protein
CTD
PMID:20656010
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
G
Fn1
fibronectin 1
multiple interactions
EXP
Berberine inhibits the reaction [Thioacetamide results in increased expression of FN1 mRNA]
CTD
PMID:30138605
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
G
Foxo1
forkhead box O1
multiple interactions
ISO
[Berberine co-treated with Niacinamide] results in increased expression of and results in increased acetylation of FOXO1 protein; Berberine results in increased expression of and results in increased acetylation of FOXO1 protein
CTD
PMID:26712469
NCBI chr 2:141,451,234...141,527,016
Ensembl chr 2:141,451,234...141,527,016
G
Foxo3
forkhead box O3
multiple interactions
ISO
[Berberine co-treated with Niacinamide] results in increased expression of and results in increased acetylation of FOXO3 protein; Berberine results in increased expression of and results in increased acetylation of FOXO3 protein
CTD
PMID:26712469
NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
G
Gdf5
growth differentiation factor 5
decreases expression
ISO
Berberine results in decreased expression of GDF5 mRNA
CTD
PMID:26478571
NCBI chr 3:151,482,672...151,487,129
Ensembl chr 3:151,483,249...151,486,693
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO EXP
Berberine inhibits the reaction [Ethanol results in increased activity of GPT protein] Berberine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Berberine inhibits the reaction [Thioacetamide results in increased activity of GPT protein]
CTD
PMID:24751971 PMID:25455889 PMID:30138605
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of GPX1 mRNA]
CTD
PMID:24751971
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions increases phosphorylation
ISO
Berberine inhibits the reaction [Dexamethasone results in decreased expression of GSK3B mRNA] Berberine results in increased phosphorylation of GSK3B protein Berberine inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein]
CTD
PMID:20462044 PMID:23954465
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
G
Gsr
glutathione-disulfide reductase
multiple interactions
EXP
Berberine inhibits the reaction [Mercuric Chloride results in decreased activity of GSR protein]
CTD
PMID:24751971 PMID:25600690
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
G
H2ac12
H2A clustered histone 12
decreases expression
ISO
Berberine results in decreased expression of H2AC12 mRNA
CTD
PMID:27311644
NCBI chr17:44,527,990...44,528,557
Ensembl chr17:44,528,125...44,528,511
G
H2ax
H2A.X variant histone
increases expression decreases expression multiple interactions
ISO
Berberine results in increased expression of H2AX protein modified form Berberine results in decreased expression of H2AX mRNA; Berberine results in decreased expression of H2AX protein TOP2A protein affects the reaction [Berberine results in increased expression of H2AX protein modified form]
CTD
PMID:23363784 PMID:23747414 PMID:27311644
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
G
H2bc12
H2B clustered histone 12
decreases expression
ISO
Berberine results in decreased expression of H2BC12 mRNA
CTD
PMID:27311644
NCBI chr17:44,527,421...44,527,801
Ensembl chr17:44,527,421...44,527,801
G
H2bc9
H2B clustered histone 9
decreases expression
ISO
Berberine results in decreased expression of H2BC9 mRNA
CTD
PMID:27311644
NCBI chr17:44,519,815...44,520,269
Ensembl chr17:44,519,860...44,520,240
G
H3c1
H3 clustered histone 1
decreases expression
ISO
Berberine results in decreased expression of H3C1 mRNA
CTD
PMID:27311644
NCBI chr17:43,616,206...43,616,735
Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131
G
H3f3a
H3.3 histone A
decreases expression
ISO
Berberine results in decreased expression of H3-3A mRNA
CTD
PMID:27311644
NCBI chr13:99,091,246...99,102,828
Ensembl chr13:99,091,763...99,101,208
G
H3f4
H3.4 histone
decreases expression
ISO
Berberine results in decreased expression of H3-4 mRNA
CTD
PMID:27311644
NCBI chr10:45,304,696...45,305,106
G
H4c3
H4 clustered histone 3
decreases expression
ISO
Berberine results in decreased expression of H4C3 mRNA
CTD
PMID:27311644
NCBI chr 4:170,144,871...170,145,311
Ensembl chr 4:170,144,951...170,145,262
G
Hat1
histone acetyltransferase 1
increases expression
ISO
Berberine results in increased expression of HAT1 mRNA
CTD
PMID:27311644
NCBI chr 3:58,022,395...58,070,067
Ensembl chr 3:58,022,238...58,070,068
G
Hdac2
histone deacetylase 2
decreases expression
ISO
Berberine results in decreased expression of HDAC2 mRNA
CTD
PMID:27311644
NCBI chr20:43,084,870...43,108,198
Ensembl chr20:43,084,870...43,108,198
G
Hdac5
histone deacetylase 5
increases expression
ISO
Berberine results in increased expression of HDAC5 mRNA
CTD
PMID:27311644
NCBI chr10:90,140,183...90,169,853
Ensembl chr10:90,140,183...90,151,042
G
Hdac8
histone deacetylase 8
decreases expression
ISO
Berberine results in decreased expression of HDAC8 mRNA
CTD
PMID:27311644
NCBI chr X:72,163,777...72,370,058
Ensembl chr X:72,163,777...72,370,044
G
Hdac9
histone deacetylase 9
decreases expression increases expression
ISO
Berberine results in decreased expression of HDAC9 mRNA Berberine results in increased expression of HDAC9 mRNA
CTD
PMID:27311644
NCBI chr 6:53,487,367...54,358,694
Ensembl chr 6:53,488,883...54,059,119
G
Hgf
hepatocyte growth factor
increases expression multiple interactions
ISO
Berberine results in increased expression of HGF mRNA; Berberine results in increased expression of HGF protein Berberine inhibits the reaction [Bleomycin results in decreased expression of HGF mRNA] 15-deoxyprostaglandin J2 promotes the reaction [Berberine results in increased expression of HGF mRNA]; 15-deoxyprostaglandin J2 promotes the reaction [Berberine results in increased expression of HGF protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Berberine results in increased expression of HGF protein]; Berberine promotes the reaction [15-deoxyprostaglandin J2 results in increased expression of HGF mRNA]; Berberine promotes the reaction [15-deoxyprostaglandin J2 results in increased expression of HGF protein]; Dactinomycin inhibits the reaction [Berberine results in increased expression of HGF protein]; PPARG mRNA promotes the reaction [Berberine results in increased expression of HGF protein]
CTD
PMID:29408570
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Hist1h2af
histone cluster 1 H2A family member F
decreases expression
ISO
Berberine results in decreased expression of H2AC8 mRNA
CTD
PMID:27311644
NCBI chr17:43,627,237...43,627,629
Ensembl chr17:43,627,237...43,627,629
G
Hist1h2ah
histone cluster 1 H2A family member H
decreases expression
ISO
Berberine results in decreased expression of H2AC11 mRNA
CTD
PMID:27311644
NCBI chr17:43,632,354...43,632,851
Ensembl chr17:44,747,796...44,748,188 Ensembl chr17:44,747,796...44,748,188
G
Hist1h2ak
histone cluster 1, H2ak
decreases expression
ISO
Berberine results in decreased expression of H2AC4 mRNA
CTD
PMID:27311644
NCBI chr17:44,840,990...44,841,382
Ensembl chr17:44,840,990...44,841,382
G
Hist1h2bd
histone cluster 1 H2B family member D
decreases expression
ISO
Berberine results in decreased expression of H2BC5 mRNA
CTD
PMID:27311644
NCBI chr17:44,833,924...44,834,305
Ensembl chr17:44,833,924...44,834,305
G
Hist1h2bl
histone cluster 1 H2B family member l
decreases expression
ISO
Berberine results in decreased expression of H2BC8 mRNA
CTD
PMID:27311644
NCBI chr17:44,748,445...44,748,910
Ensembl chr17:44,748,482...44,748,862
G
Hist1h2bq
histone cluster 1 H2B family member Q
decreases expression
ISO
Berberine results in decreased expression of H2BC7 mRNA
CTD
PMID:27311644
NCBI chr17:43,679,925...43,689,311
Ensembl chr17:43,679,925...43,689,311
G
Hist1h3b
histone cluster 1, H3b
decreases expression
ISO
Berberine results in decreased expression of H3C12 mRNA
CTD
PMID:27311644
NCBI chr17:44,760,023...44,764,058
Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131
G
Hist1h4b
histone cluster 1 H4 family member B
decreases expression
ISO
Berberine results in decreased expression of H4C9 mRNA
CTD
PMID:27311644
NCBI chr17:44,522,144...44,526,587
Ensembl chr17:44,522,140...44,526,583
G
Hist2h2aa3
histone cluster 2 H2A family member A3
decreases expression
ISO
Berberine results in decreased expression of H2AC18 mRNA
CTD
PMID:27311644
NCBI chr 2:198,388,766...198,389,293
Ensembl chr 2:198,388,809...198,389,201 Ensembl chr 2:198,388,809...198,389,201
G
Hist2h2be
histone cluster 2 H2B family member E
decreases expression
ISO
Berberine results in decreased expression of H2BC11 mRNA
CTD
PMID:27311644
NCBI chr 2:198,360,837...198,363,399
Ensembl chr 2:198,360,998...198,361,378
G
Hist2h4
histone cluster 2, H4
decreases expression
ISO
Berberine results in decreased expression of H4C2 mRNA
CTD
PMID:27311644
NCBI chr 2:198,411,955...198,412,350
Ensembl chr 2:198,411,955...198,412,350
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO
Berberine results in increased expression of HMOX1 protein Berberine promotes the reaction [Glucose results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [Berberine results in increased expression of HMOX1 protein]
CTD
PMID:23954465
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hnf4a
hepatocyte nuclear factor 4, alpha
multiple interactions
EXP ISO
Berberine inhibits the reaction [Fructose results in decreased expression of HNF4A mRNA]; Berberine inhibits the reaction [Fructose results in decreased expression of HNF4A protein] Berberine inhibits the reaction [Ethanol results in decreased expression of HNF4 protein]
CTD
PMID:18563319 PMID:25455889
NCBI chr 3:159,902,441...159,965,003
Ensembl chr 3:159,902,441...159,965,003
G
Idh3a
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
decreases expression
ISO
Berberine results in decreased expression of IDH3A mRNA
CTD
PMID:30818834
NCBI chr 8:59,164,601...59,183,899
Ensembl chr 8:59,164,572...59,183,908
G
Ifng
interferon gamma
multiple interactions
EXP
Berberine inhibits the reaction [Thioacetamide results in increased expression of IFNG mRNA]
CTD
PMID:30138605
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Igf1r
insulin-like growth factor 1 receptor
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Glucose results in decreased expression of IGF1R protein] Berberine results in increased expression of IGF1R protein
CTD
PMID:23954465
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
G
Il10
interleukin 10
multiple interactions increases expression
ISO EXP
Berberine affects the reaction [Lipopolysaccharides affects the expression of IL10 mRNA] [Berberine co-treated with Thioacetamide] results in increased expression of IL10 mRNA Berberine results in increased expression of IL10 mRNA
CTD
PMID:21867779 PMID:30138605
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il1b
interleukin 1 beta
multiple interactions
ISO EXP
Berberine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Berberine inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Berberine inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; Berberine inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased expression of IL1B protein]; Berberine inhibits the reaction [Thioacetamide results in increased expression of IL1B mRNA]
CTD
PMID:16391493 PMID:29170048 PMID:30138605
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il2
interleukin 2
increases expression
ISO
Berberine results in increased expression of IL2 mRNA
CTD
PMID:21867779
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Il23a
interleukin 23 subunit alpha
multiple interactions
ISO
Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of IL23A mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of IL23A protein]
CTD
PMID:30240693
NCBI chr 7:2,710,609...2,712,723
Ensembl chr 7:2,710,609...2,712,723
G
Il4
interleukin 4
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Lipopolysaccharides results in decreased expression of IL4 mRNA] Berberine results in increased expression of IL4 mRNA
CTD
PMID:21867779
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
G
Il6
interleukin 6
multiple interactions
EXP ISO
Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased expression of IL6 protein]; Berberine inhibits the reaction [Thioacetamide results in increased expression of IL6 mRNA]; Berberine inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of IL6 mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of IL6 protein] Berberine inhibits the reaction [Mustard Gas results in increased secretion of IL6 protein]
CTD
PMID:28916288 PMID:29170048 PMID:30138605 PMID:30240693
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Itga1
integrin subunit alpha 1
increases expression
ISO
Berberine results in increased expression of ITGA1 mRNA
CTD
PMID:26478571
NCBI chr 2:47,127,403...47,281,387
Ensembl chr 2:47,127,219...47,281,421
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
affects localization multiple interactions
EXP
Berberine affects the localization of JUN protein arsenic trioxide promotes the reaction [Berberine affects the localization of JUN protein]
CTD
PMID:18294404
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions
EXP
Berberine results in decreased activity of KCNH2 protein Berberine promotes the reaction [Atorvastatin results in decreased activity of KCNH2 protein]; Berberine promotes the reaction [Simvastatin results in decreased activity of KCNH2 protein]
CTD
PMID:30086269
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
G
Kdm1a
lysine demethylase 1A
increases expression
ISO
Berberine results in increased expression of KDM1A mRNA
CTD
PMID:27311644
NCBI chr 5:154,909,003...154,965,171
Ensembl chr 5:154,909,003...154,965,171
G
Kdm4a
lysine demethylase 4A
increases expression
ISO
Berberine results in increased expression of KDM4A mRNA
CTD
PMID:27311644
NCBI chr 5:136,967,650...137,014,402
Ensembl chr 5:136,967,650...137,014,430
G
Kdm5b
lysine demethylase 5B
increases expression
ISO
Berberine results in increased expression of KDM5B mRNA
CTD
PMID:27311644
NCBI chr13:51,384,371...51,455,392
Ensembl chr13:51,384,389...51,455,357
G
Kdm6a
lysine demethylase 6A
increases expression
ISO
Berberine results in increased expression of KDM6A mRNA
CTD
PMID:27311644
NCBI chr X:4,805,493...4,945,788
Ensembl chr X:4,806,277...4,945,944
G
Kdm6b
lysine demethylase 6B
increases expression
ISO
Berberine results in increased expression of KDM6B mRNA
CTD
PMID:27311644
NCBI chr10:56,000,494...56,009,582
Ensembl chr10:56,001,799...56,008,885
G
Kmt5a
lysine methyltransferase 5A
increases expression
ISO
Berberine results in increased expression of KMT5A mRNA
CTD
PMID:27311644
NCBI chr12:37,558,150...37,581,183
Ensembl chr12:37,559,770...37,574,750
G
Ldlr
low density lipoprotein receptor
multiple interactions increases expression
ISO EXP
Berberine inhibits the reaction [Clozapine results in increased expression of LDLR mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of LDLR mRNA] Berberine results in increased expression of LDLR mRNA Berberine promotes the reaction [Simvastatin results in increased expression of LDLR mRNA]; Simvastatin promotes the reaction [Berberine results in increased expression of LDLR mRNA]
CTD
PMID:18640378 PMID:20564506
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
G
LOC103690190
histone H2A type 1-E
decreases expression
ISO
Berberine results in decreased expression of H2AC6 mRNA
CTD
PMID:27311644
NCBI chr17:44,747,686...44,748,229
Ensembl chr17:44,747,796...44,748,188 Ensembl chr17:44,747,796...44,748,188
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
multiple interactions
ISO
Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in decreased expression of and results in increased phosphorylation of MAP3K5 protein]
CTD
PMID:30240693
NCBI chr 1:15,412,603...15,613,752
Ensembl chr 1:15,412,603...15,613,746
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
EXP
Berberine results in decreased phosphorylation of MAPK1 protein
CTD
PMID:18294404
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation multiple interactions
EXP ISO
Berberine results in decreased phosphorylation of MAPK3 protein Berberine inhibits the reaction [Dexamethasone results in decreased expression of MAPK3 mRNA]
CTD
PMID:18294404 PMID:20462044
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mapt
microtubule-associated protein tau
multiple interactions
EXP
Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased expression of MAPT mRNA]
CTD
PMID:29170048
NCBI chr10:92,289,002...92,386,517
Ensembl chr10:92,288,910...92,386,517
G
Mcm2
minichromosome maintenance complex component 2
multiple interactions
ISO
Berberine inhibits the reaction [Dexamethasone results in increased expression of MCM2 mRNA]
CTD
PMID:20462044
NCBI chr 4:120,825,699...120,840,221
Ensembl chr 4:120,825,699...120,840,111
G
Mir19a
microRNA 19a
decreases expression
ISO
Berberine results in decreased expression of MIR19A mRNA
CTD
PMID:29687521
NCBI chr15:100,180,162...100,180,243
Ensembl chr15:100,180,162...100,180,243
G
Mir92a1
microRNA 92a-1
decreases expression
ISO
Berberine results in decreased expression of MIR92A1 mRNA
CTD
PMID:29687521
NCBI chr15:100,180,586...100,180,663
Ensembl chr15:100,180,586...100,180,663
G
Mmp13
matrix metallopeptidase 13
increases expression
ISO
Berberine results in increased expression of MMP13 mRNA
CTD
PMID:26478571
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
G
Mmp14
matrix metallopeptidase 14
multiple interactions decreases expression
EXP
arsenic trioxide promotes the reaction [Berberine results in decreased expression of MMP14 protein]
CTD
PMID:18294404
NCBI chr15:33,074,441...33,083,666
Ensembl chr15:33,074,441...33,083,655
G
Mmp2
matrix metallopeptidase 2
multiple interactions decreases activity decreases expression
ISO EXP
arsenic trioxide promotes the reaction [Berberine results in decreased activity of MMP2 protein]; Berberine promotes the reaction [arsenic trioxide results in decreased activity of MMP2 protein] Berberine results in decreased expression of MMP2 protein arsenic trioxide promotes the reaction [Berberine results in decreased activity of MMP2 protein]; arsenic trioxide promotes the reaction [Berberine results in decreased expression of MMP2 protein]; Berberine promotes the reaction [arsenic trioxide results in decreased activity of MMP2 protein]
CTD
PMID:18294404
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mpo
myeloperoxidase
multiple interactions
ISO
Berberine inhibits the reaction [Lipopolysaccharides results in increased expression of MPO protein]
CTD
PMID:21963898
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
G
Mttp
microsomal triglyceride transfer protein
multiple interactions
ISO
Berberine inhibits the reaction [Ethanol results in decreased expression of MTTP protein]
CTD
PMID:25455889
NCBI chr 2:243,366,181...243,407,608
Ensembl chr 2:243,366,181...243,407,608
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions affects localization
EXP
arsenic trioxide promotes the reaction [Berberine affects the localization of MYC protein]
CTD
PMID:18294404
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Nampt
nicotinamide phosphoribosyltransferase
multiple interactions decreases expression
ISO
[Berberine co-treated with Niacinamide] results in decreased expression of NAMPT protein; SRT1720 inhibits the reaction [Berberine results in decreased expression of NAMPT protein]
CTD
PMID:26712469
NCBI chr 6:52,122,085...52,156,473
Ensembl chr 6:52,122,085...52,156,472
G
Nfe2l2
nuclear factor, erythroid 2-like 2
increases expression increases activity multiple interactions
ISO EXP
Berberine results in increased expression of NFE2L2 protein Berberine results in increased activity of NFE2L2 protein Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein] NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]]; NFE2L2 mutant form inhibits the reaction [Berberine results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [Berberine results in increased expression of NGF protein]
CTD
PMID:23523906 PMID:23954465 PMID:30818834
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
Berberine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]
CTD
PMID:21963898
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Ngf
nerve growth factor
multiple interactions
ISO
Berberine inhibits the reaction [Glucose results in decreased expression of NGF protein]; NFE2L2 mutant form inhibits the reaction [Berberine results in increased expression of NGF protein]
CTD
PMID:23954465
NCBI chr 2:204,886,158...204,939,523
Ensembl chr 2:204,886,202...204,940,453
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO EXP
Berberine inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] Berberine inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]
CTD
PMID:21095217 PMID:23523906
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
IEP
Berberine reverses reaction [Carbon tetrachloride decreases Nqo1 mRNA in liver]
RGD
PMID:31432116
RGD:25823187
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity multiple interactions
ISO
Berberine results in increased activity of NR1I2 protein [Berberine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD
PMID:21524698
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
Berberine results in increased activity of NR1I3 protein
CTD
PMID:30818834
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
G
Nsd2
nuclear receptor binding SET domain protein 2
decreases expression
ISO
Berberine results in decreased expression of NSD2 mRNA
CTD
PMID:27311644
NCBI chr14:82,119,210...82,196,501
Ensembl chr14:82,119,210...82,171,480
G
Odc1
ornithine decarboxylase 1
multiple interactions decreases expression
EXP
arsenic trioxide promotes the reaction [Berberine results in decreased expression of ODC1 protein]
CTD
PMID:18294404
NCBI chr 6:42,852,529...42,859,142
Ensembl chr 6:42,852,683...42,859,927
G
Omd
osteomodulin
increases expression
ISO
Berberine results in increased expression of OMD mRNA
CTD
PMID:26478571
NCBI chr17:15,476,100...15,484,324
Ensembl chr17:15,475,710...15,484,269 Ensembl chr17:15,475,710...15,484,269
G
P2rx7
purinergic receptor P2X 7
multiple interactions
ISO
Berberine affects the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in increased activity of P2RX7 protein]
CTD
PMID:21320518
NCBI chr12:39,353,613...39,396,042
Ensembl chr12:39,353,613...39,396,042
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
Berberine results in increased cleavage of PARP1 protein [Berberine co-treated with Niacinamide] results in increased cleavage of PARP1 protein
CTD
PMID:16505103 PMID:26712469
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
Berberine inhibits the reaction [Ethanol results in decreased expression of PPARA mRNA]
CTD
PMID:25455889
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases response to substance increases expression decreases expression
ISO
Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]; Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein]; Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein] 15-deoxyprostaglandin J2 promotes the reaction [Berberine affects the localization of and results in increased activity of PPARG protein]; Berberine inhibits the reaction [Bleomycin binds to PPARG protein]; Berberine promotes the reaction [15-deoxyprostaglandin J2 affects the localization of and results in increased activity of PPARG protein]; Berberine results in increased activity of and affects the localization of PPARG protein; PPARG mRNA promotes the reaction [Berberine results in increased expression of HGF protein] PPARG mRNA results in increased susceptibility to Berberine Berberine results in increased expression of PPARG mRNA Berberine results in decreased expression of PPARG mRNA
CTD
PMID:20564506 PMID:26478571 PMID:29408570
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions
ISO
Berberine inhibits the reaction [Ethanol results in decreased expression of PPARGC1A mRNA]
CTD
PMID:25455889
NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
G
Prg4
proteoglycan 4
decreases expression
ISO
Berberine results in decreased expression of PRG4 mRNA
CTD
PMID:26478571
NCBI chr13:67,672,588...67,688,902
Ensembl chr13:67,672,878...67,688,477
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
increases phosphorylation
ISO
Berberine results in increased phosphorylation of PRKAA1 protein
CTD
PMID:28298333
NCBI chr 2:54,857,688...54,893,404
Ensembl chr 2:54,857,688...54,893,404
G
Prkca
protein kinase C, alpha
multiple interactions
EXP
arsenic trioxide promotes the reaction [Berberine results in decreased activity of PRKCA protein]; Berberine results in decreased activity of and affects the localization of PRKCA protein
CTD
PMID:18294404
NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
G
Prkce
protein kinase C, epsilon
multiple interactions decreases activity
EXP
arsenic trioxide promotes the reaction [Berberine results in decreased activity of PRKCE protein]; Berberine results in decreased activity of and affects the localization of PRKCE protein
CTD
PMID:18294404
NCBI chr 6:9,483,400...9,973,396
Ensembl chr 6:9,790,422...9,973,396
G
Prmt1
protein arginine methyltransferase 1
decreases expression
ISO
Berberine results in decreased expression of PRMT1 mRNA
CTD
PMID:27311644
NCBI chr 1:100,971,132...100,980,411
Ensembl chr 1:100,971,273...100,980,340
G
Prmt2
protein arginine methyltransferase 2
increases expression
ISO
Berberine results in increased expression of PRMT2 mRNA
CTD
PMID:27311644
NCBI chr20:13,154,513...13,212,613
Ensembl chr20:13,156,241...13,212,606
G
Prmt5
protein arginine methyltransferase 5
increases expression
ISO
Berberine results in increased expression of PRMT5 mRNA
CTD
PMID:27311644
NCBI chr15:33,156,508...33,165,893
Ensembl chr15:33,156,492...33,165,895
G
Prmt6
protein arginine methyltransferase 6
increases expression
ISO
Berberine results in increased expression of PRMT6 mRNA
CTD
PMID:27311644
NCBI chr 2:213,173,403...213,180,721
Ensembl chr 2:213,173,403...213,178,632 Ensembl chr 2:213,173,403...213,178,632
G
Prmt7
protein arginine methyltransferase 7
increases expression
ISO
Berberine results in increased expression of PRMT7 mRNA
CTD
PMID:27311644
NCBI chr19:38,189,605...38,237,155
Ensembl chr19:38,189,605...38,237,308
G
Prmt8
protein arginine methyltransferase 8
increases expression
ISO
Berberine results in increased expression of PRMT8 mRNA
CTD
PMID:27311644
NCBI chr 4:160,253,409...160,334,647
Ensembl chr 4:160,253,073...160,334,910
G
Pten
phosphatase and tensin homolog
multiple interactions increases expression
ISO
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) inhibits the reaction [Berberine inhibits the reaction [Bleomycin results in decreased expression of PTEN mRNA]]; Berberine inhibits the reaction [Bleomycin results in decreased expression of PTEN mRNA]; Berberine inhibits the reaction [Bleomycin results in decreased expression of PTEN protein] Berberine results in increased expression of PTEN protein
CTD
PMID:29408570
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
Berberine inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]
CTD
PMID:21095217
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Rbp4
retinol binding protein 4
multiple interactions
EXP
Berberine inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased secretion of RBP4 protein]
CTD
PMID:19080170
NCBI chr 1:256,806,476...256,813,678
Ensembl chr 1:256,806,472...256,813,711
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Berberine inhibits the reaction [Bleomycin affects the localization of and results in increased expression of RELA protein]
CTD
PMID:23523906
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
RGD1562378
histone H4 variant H4-v.1
decreases expression
ISO
Berberine results in decreased expression of H4C14 mRNA
CTD
PMID:27311644
NCBI chr 4:170,762,862...170,763,962
Ensembl chr 4:170,763,605...170,763,916
G
Rln1
relaxin 1
affects binding increases expression multiple interactions
EXP
Berberine binds to RLN1 promoter Berberine results in increased expression of RLN1 mRNA [Berberine binds to RLN1 promoter] which results in increased expression of RLN1 mRNA
CTD
PMID:22363579
NCBI chr 1:247,483,298...247,486,331
Ensembl chr 1:247,483,302...247,486,202
G
Rps6
ribosomal protein S6
decreases phosphorylation
ISO
Berberine results in decreased phosphorylation of RPS6 protein
CTD
PMID:23363784
NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148 Ensembl chr 5:105,197,857...105,200,148
G
Runx2
RUNX family transcription factor 2
multiple interactions increases expression
ISO
CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of RUNX2 mRNA]; DKK1 protein inhibits the reaction [Berberine results in increased expression of RUNX2 mRNA]
CTD
PMID:26478571
NCBI chr 9:18,564,743...18,773,092
Ensembl chr 9:18,564,927...18,773,092
G
Setd1b
SET domain containing 1B, histone lysine methyltransferase
increases expression
ISO
Berberine results in increased expression of SETD1B mRNA
CTD
PMID:27311644
NCBI chr12:38,843,167...38,869,180
Ensembl chr12:38,845,621...38,869,346
G
Setd2
SET domain containing 2, histone lysine methyltransferase
increases expression
ISO
Berberine results in increased expression of SETD2 mRNA
CTD
PMID:27311644
NCBI chr 8:118,802,478...118,888,224
Ensembl chr 8:118,803,075...118,888,224
G
Setd3
SET domain containing 3, actin histidine methyltransferase
increases expression
ISO
Berberine results in increased expression of SETD3 mRNA
CTD
PMID:27311644
NCBI chr 6:132,023,128...132,090,072
Ensembl chr 6:132,023,945...132,075,875
G
Setd5
SET domain containing 5
increases expression
ISO
Berberine results in increased expression of SETD5 mRNA
CTD
PMID:27311644
NCBI chr 4:145,017,549...145,095,247
Ensembl chr 4:145,017,608...145,095,245
G
Setd6
SET domain containing 6, protein lysine methyltransferase
increases expression
ISO
Berberine results in increased expression of SETD6 mRNA
CTD
PMID:27311644
NCBI chr19:9,758,613...9,766,333
Ensembl chr19:9,762,489...9,765,484
G
Setd7
SET domain containing 7, histone lysine methyltransferase
increases expression
ISO
Berberine results in increased expression of SETD7 mRNA
CTD
PMID:27311644
NCBI chr 2:140,576,188...140,618,405
Ensembl chr 2:140,576,188...140,618,405
G
Setdb1
SET domain bifurcated histone lysine methyltransferase 1
increases expression
ISO
Berberine results in increased expression of SETDB1 mRNA
CTD
PMID:27311644
NCBI chr 2:196,495,867...196,527,412
Ensembl chr 2:196,495,867...196,527,127
G
Setdb2
SET domain bifurcated histone lysine methyltransferase 2
increases expression
ISO
Berberine results in increased expression of SETDB2 mRNA
CTD
PMID:27311644
NCBI chr15:38,699,135...39,745,035
Ensembl chr15:39,712,861...39,742,103 Ensembl chr15:39,712,861...39,742,103
G
Si
sucrase-isomaltase
decreases expression multiple interactions
ISO EXP
Berberine results in decreased expression of SI mRNA N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Berberine results in decreased expression of SI mRNA]
CTD
PMID:20229011
NCBI chr 2:170,220,794...170,301,348
Ensembl chr 2:170,221,245...170,301,348
G
Sirt1
sirtuin 1
decreases expression multiple interactions
ISO
Berberine results in decreased expression of SIRT1 mRNA; Berberine results in decreased expression of SIRT1 protein [Berberine co-treated with Niacinamide] results in decreased expression of SIRT1 protein; SRT1720 inhibits the reaction [Berberine results in decreased expression of SIRT1 protein]
CTD
PMID:26712469
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
G
Sirt2
sirtuin 2
multiple interactions
ISO
[Berberine co-treated with Niacinamide] results in decreased expression of SIRT2 protein
CTD
PMID:26712469
NCBI chr 1:86,948,866...86,971,954
Ensembl chr 1:86,948,918...86,971,952
G
Sirt3
sirtuin 3
multiple interactions increases expression decreases expression
ISO
[Berberine co-treated with Niacinamide] results in decreased expression of SIRT3 protein Berberine results in increased expression of SIRT3 mRNA Berberine results in decreased expression of SIRT3 mRNA; Berberine results in decreased expression of SIRT3 protein
CTD
PMID:26712469 PMID:27311644
NCBI chr 1:213,613,502...213,636,061
Ensembl chr 1:213,613,513...213,635,546
G
Slc27a5
solute carrier family 27 member 5
decreases expression
ISO
Berberine results in decreased expression of SLC27A5 mRNA
CTD
PMID:28038998
NCBI chr 1:65,576,599...65,587,192
Ensembl chr 1:65,576,535...65,587,186
G
Slc2a4
solute carrier family 2 member 4
multiple interactions
EXP
Berberine inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of SLC2A4 protein]
CTD
PMID:19080170
NCBI chr10:56,552,921...56,558,562
Ensembl chr10:56,552,983...56,558,487
G
Slc6a19
solute carrier family 6 member 19
multiple interactions
EXP
Berberine affects the reaction [Lipopolysaccharides affects the expression of SLC6A19 mRNA]; Berberine affects the reaction [Lipopolysaccharides affects the expression of SLC6A19 protein]
CTD
PMID:21073932
NCBI chr 1:32,199,869...32,218,628
Ensembl chr 1:32,199,810...32,220,045
G
Smyd3
SET and MYND domain containing 3
affects expression
ISO
Berberine affects the expression of SMYD3 mRNA
CTD
PMID:27311644
NCBI chr13:97,330,120...97,807,813
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
Berberine inhibits the reaction [Carbon Tetrachloride results in decreased activity of SOD1 protein]; Berberine inhibits the reaction [Streptozocin affects the expression of SOD1 mRNA]
CTD
PMID:21095217 PMID:22775417
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Sod2
superoxide dismutase 2
multiple interactions
ISO EXP
Berberine inhibits the reaction [Streptozocin affects the expression of SOD2 mRNA] Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of SOD2 mRNA]
CTD
PMID:22775417 PMID:24751971
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
G
Sox9
SRY-box transcription factor 9
decreases expression
ISO
Berberine results in decreased expression of SOX9 mRNA
CTD
PMID:26478571
NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
G
Sp7
Sp7 transcription factor
increases expression
ISO
Berberine results in increased expression of SP7 mRNA
CTD
PMID:26478571
NCBI chr 7:143,957,316...143,967,488
Ensembl chr 7:143,958,858...143,967,484
G
Sparc
secreted protein acidic and cysteine rich
increases expression
ISO
Berberine results in increased expression of SPARC mRNA
CTD
PMID:26478571
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
G
Spp1
secreted phosphoprotein 1
increases expression multiple interactions
ISO
Berberine results in increased expression of SPP1 mRNA; Berberine results in increased expression of SPP1 protein CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of SPP1 protein]; DKK1 protein inhibits the reaction [Berberine results in increased expression of SPP1 protein]
CTD
PMID:26478571
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions decreases expression
ISO
Berberine inhibits the reaction [Clozapine results in increased expression of SREBF1 mRNA]; Berberine inhibits the reaction [Clozapine results in increased expression of SREBF1 protein]; Berberine inhibits the reaction [Risperidone results in increased expression of SREBF1 mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of SREBF1 protein] Berberine results in decreased expression of SREBF1 mRNA
CTD
PMID:20564506 PMID:26478571
NCBI chr10:46,570,996...46,593,021
Ensembl chr10:46,570,996...46,593,009
G
Tert
telomerase reverse transcriptase
decreases activity
ISO
Berberine results in decreased activity of TERT protein
CTD
PMID:25265580
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
G
Tgfb1
transforming growth factor, beta 1
decreases expression multiple interactions
EXP
Berberine results in decreased expression of TGFB1 protein Berberine inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]; Berberine inhibits the reaction [Thioacetamide results in increased expression of TGFB1 mRNA]
CTD
PMID:17973934 PMID:23523906 PMID:30138605
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of TLR4 mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of TLR4 protein]; Berberine inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]
CTD
PMID:21963898 PMID:30240693
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
G
Tnf
tumor necrosis factor
multiple interactions increases secretion increases expression
ISO EXP
Berberine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; Berberine inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Berberine inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]; Berberine inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein] Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased expression of TNF mRNA]; Berberine inhibits the reaction [[Cadmium co-treated with Aluminum co-treated with Fluorides] results in increased expression of TNF protein]; Berberine inhibits the reaction [Bleomycin results in increased expression of TNF protein]; Berberine inhibits the reaction [Mercuric Chloride results in increased expression of TNF protein] Berberine results in increased secretion of TNF protein Berberine results in increased expression of TNF mRNA Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in decreased expression of and results in increased phosphorylation of MAP3K5 protein]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of IL23A mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of IL6 mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of TLR4 mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of TRAF2 mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of IL23A protein]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of IL6 protein]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of TLR4 protein]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of TRAF2 protein]; Berberine inhibits the reaction [Benzo(a)pyrene results in increased expression of TNF mRNA]; Berberine inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Berberine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]
CTD
PMID:16391493 PMID:20656010 PMID:21095217 PMID:21867779 PMID:23523906 PMID:25600690 PMID:28533128 PMID:29170048 PMID:30240693
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
G
Top1
DNA topoisomerase I
decreases activity
ISO
Berberine results in decreased activity of TOP1 protein
CTD
PMID:23747414
NCBI chr 3:156,635,688...156,717,686
Ensembl chr 3:156,642,464...156,717,686
G
Top2a
DNA topoisomerase II alpha
multiple interactions affects response to substance
ISO
TOP2A protein affects the reaction [Berberine results in increased expression of H2AX protein modified form] TOP2A protein affects the susceptibility to Berberine
CTD
PMID:23747414
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
Berberine results in increased expression of TP53 mRNA; Berberine results in increased expression of TP53 protein [Berberine co-treated with Niacinamide] results in increased expression of and results in increased acetylation of TP53 protein; Berberine results in increased phosphorylation of and results in increased acetylation of TP53 protein
CTD
PMID:20656010 PMID:26712469
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
Berberine results in increased expression of TRAF1 protein
CTD
PMID:20656010
NCBI chr 3:14,003,340...14,022,955
Ensembl chr 3:14,003,340...14,022,672
G
Traf2
Tnf receptor-associated factor 2
multiple interactions
ISO
Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of TRAF2 mRNA]; Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of TRAF2 protein]
CTD
PMID:30240693
NCBI chr 3:2,746,061...2,770,690
Ensembl chr 3:2,746,075...2,770,620
G
Tstd1
thiosulfate sulfurtransferase like domain containing 1
increases expression
ISO
Berberine results in increased expression of TSTD1 mRNA
CTD
PMID:27311644
NCBI chr13:89,805,652...89,807,355
Ensembl chr13:89,805,962...89,807,243
G
Ube2a
ubiquitin-conjugating enzyme E2A
decreases expression
ISO
Berberine results in decreased expression of UBE2A mRNA
CTD
PMID:27311644
NCBI chr X:123,486,988...123,497,726
Ensembl chr X:123,486,989...123,497,726
G
Ube2b
ubiquitin-conjugating enzyme E2B
decreases expression
ISO
Berberine results in decreased expression of UBE2B mRNA
CTD
PMID:27311644
NCBI chr10:37,439,947...37,454,867
Ensembl chr10:37,441,284...37,455,022
G
Ucp2
uncoupling protein 2
multiple interactions
ISO
Berberine inhibits the reaction [Benzo(a)pyrene results in increased expression of UCP2 mRNA]
CTD
PMID:28533128
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
G
Vegfc
vascular endothelial growth factor C
increases expression
ISO
Berberine results in increased expression of VEGFC mRNA
CTD
PMID:26478571
NCBI chr16:40,440,371...40,555,178
Ensembl chr16:40,440,207...40,555,576
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
ISO
canadine results in increased expression of CYP1A2 mRNA; canadine results in increased expression of CYP1A2 protein
CTD
PMID:28257954
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression
ISO
canadine results in increased expression of CYP2E1 mRNA; canadine results in increased expression of CYP2E1 protein
CTD
PMID:28257954
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
G
Cdh5
cadherin 5
increases expression
ISO
columbamine results in increased expression of CDH5 mRNA
CTD
PMID:23124089
NCBI chr19:1,025,122...1,074,333
Ensembl chr19:1,023,683...1,074,365
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
columbamine results in decreased expression of CDK6 mRNA; columbamine results in decreased expression of CDK6 protein
CTD
PMID:23124089
NCBI chr 4:27,781,728...27,969,653
Ensembl chr 4:27,785,647...27,966,398
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
columbamine inhibits the reaction [CSF2 protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:23124089
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
G
Ephb2
Eph receptor B2
decreases expression
ISO
columbamine results in decreased expression of EPHB2 mRNA
CTD
PMID:23124089
NCBI chr 5:155,024,478...155,143,539
Ensembl chr 5:155,022,493...155,204,456
G
Maged1
MAGE family member D1
decreases expression
ISO
columbamine results in decreased expression of MAGED1 mRNA
CTD
PMID:23124089
NCBI chr X:63,803,194...63,809,715
Ensembl chr X:63,803,189...63,809,861
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
columbamine results in decreased expression of MMP2 mRNA
CTD
PMID:23124089
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Sox17
SRY-box transcription factor 17
decreases expression
ISO
columbamine results in decreased expression of SOX17 mRNA
CTD
PMID:23124089
NCBI chr 5:14,890,318...14,895,907
Ensembl chr 5:14,890,408...14,895,907
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
columbamine inhibits the reaction [CSF2 protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:23124089
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases export increases expression
ISO EXP
palmatine inhibits the reaction [ABCB1A protein results in increased export of Fluorescent Dyes] ABCB1A protein results in increased export of palmatine palmatine results in increased expression of ABCB1A mRNA
CTD
PMID:20410605
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
increases expression
EXP
palmatine results in increased expression of ABCB1B mRNA
CTD
PMID:20410605
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
palmatine results in increased expression of AHR mRNA
CTD
PMID:24583342
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
G
Birc5
baculoviral IAP repeat-containing 5
affects binding
ISO
palmatine binds to BIRC5 promoter
CTD
PMID:17968851
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
palmatine results in decreased expression of CCL2 protein
CTD
PMID:20116850
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
ISO
palmatine results in decreased expression of CCL3 protein
CTD
PMID:20116850
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
ISO
palmatine results in decreased expression of CCL4 protein
CTD
PMID:20116850
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
G
Ccl5
C-C motif chemokine ligand 5
decreases expression
ISO
palmatine results in decreased expression of CCL5 protein
CTD
PMID:20116850
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
palmatine results in increased expression of CYP1A1 mRNA
CTD
PMID:24583342
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
H2ax
H2A.X variant histone
increases expression
ISO
palmatine results in increased expression of H2AX protein modified form
CTD
PMID:23747414
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
G
Il6r
interleukin 6 receptor
decreases expression
ISO
palmatine results in decreased expression of IL6R protein modified form
CTD
PMID:20116850
NCBI chr 2:189,196,180...189,255,987
Ensembl chr 2:189,205,701...189,254,628
G
Top1
DNA topoisomerase I
decreases activity
ISO
palmatine results in decreased activity of TOP1 protein
CTD
PMID:23747414
NCBI chr 3:156,635,688...156,717,686
Ensembl chr 3:156,642,464...156,717,686
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
palmatine results in decreased expression of VEGFA protein
CTD
PMID:20116850
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Abcf1
ATP binding cassette subfamily F member 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ABCF1 protein
CTD
PMID:20109541
NCBI chr20:3,309,914...3,322,828
Ensembl chr20:3,309,899...3,322,825
G
Acbd3
acyl-CoA binding domain containing 3
increases expression
ISO
tetrahydropalmatine results in increased expression of ACBD3 protein
CTD
PMID:20109541
NCBI chr13:99,004,942...99,035,520
Ensembl chr13:99,004,942...99,035,519
G
Acot9
acyl-CoA thioesterase 9
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ACOT9 protein
CTD
PMID:20109541
NCBI chr X:43,543,069...43,592,200
Ensembl chr X:43,543,070...43,592,200
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
increases expression
ISO
tetrahydropalmatine results in increased expression of ALDH5A1 protein
CTD
PMID:20109541
NCBI chr17:42,133,076...42,159,413
Ensembl chr17:42,133,076...42,159,413
G
Ap2a1
adaptor related protein complex 2 subunit alpha 1
increases expression
ISO
tetrahydropalmatine results in increased expression of AP2A1 protein
CTD
PMID:20109541
NCBI chr 1:100,896,582...100,926,443
Ensembl chr 1:100,896,947...100,926,335
G
Arhgap1
Rho GTPase activating protein 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ARHGAP1 protein
CTD
PMID:20109541
NCBI chr 3:80,555,196...80,576,881
Ensembl chr 3:80,555,196...80,576,856
G
Arih1
ariadne RBR E3 ubiquitin protein ligase 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ARIH1 protein
CTD
PMID:20109541
NCBI chr 8:64,166,359...64,268,555
Ensembl chr 8:64,166,360...64,268,555
G
Arpc3
actin related protein 2/3 complex, subunit 3
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ARPC3 protein
CTD
PMID:20109541
NCBI chr12:39,653,951...39,667,817
Ensembl chr12:39,653,953...39,667,849
G
Arpp19
cAMP-regulated phosphoprotein 19
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ARPP19 protein
CTD
PMID:20109541
NCBI chr 8:81,949,577...81,972,054
Ensembl chr 8:81,949,877...81,968,589
G
Atad3a
ATPase family, AAA domain containing 3A
increases expression
ISO
tetrahydropalmatine results in increased expression of ATAD3A protein
CTD
PMID:20109541
NCBI chr 5:173,189,590...173,209,809
Ensembl chr 5:173,189,592...173,209,768
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ATP2B1 protein
CTD
PMID:20109541
NCBI chr 7:41,114,606...41,223,138
Ensembl chr 7:41,114,697...41,220,579
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
tetrahydropalmatine results in increased expression of BAD protein
CTD
PMID:20109541
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
tetrahydropalmatine results in increased expression of BAX protein
CTD
PMID:20109541
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcar1
BCAR1 scaffold protein, Cas family member
decreases expression
ISO
tetrahydropalmatine results in decreased expression of BCAR1 protein
CTD
PMID:20109541
NCBI chr19:43,932,543...43,967,452
Ensembl chr19:43,932,554...43,955,783
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
tetrahydropalmatine results in decreased expression of BCL2 protein
CTD
PMID:20109541
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bzw1
basic leucine zipper and W2 domains 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of BZW1 protein
CTD
PMID:20109541
NCBI chr 9:65,279,675...65,293,471
Ensembl chr 9:65,279,675...65,291,651
G
Cald1
caldesmon 1
decreases expression increases expression
ISO
tetrahydropalmatine results in decreased expression of CALD1 protein tetrahydropalmatine results in increased expression of CALD1 protein
CTD
PMID:20109541
NCBI chr 4:62,103,948...62,291,375
Ensembl chr 4:62,220,736...62,291,489
G
Calu
calumenin
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CALU protein
CTD
PMID:20109541
NCBI chr 4:56,625,611...56,653,112
Ensembl chr 4:56,625,561...56,653,111
G
Casp3
caspase 3
increases cleavage
ISO
tetrahydropalmatine results in increased cleavage of CASP3 protein
CTD
PMID:20109541
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Cavin3
caveolae associated protein 3
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CAVIN3 protein
CTD
PMID:20109541
NCBI chr 1:170,317,099...170,318,688
Ensembl chr 1:170,317,113...170,318,935
G
Cc2d1b
coiled-coil and C2 domain containing 1B
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CC2D1B protein
CTD
PMID:20109541
NCBI chr 5:128,215,711...128,229,762
Ensembl chr 5:128,215,711...128,229,737
G
Ckap5
cytoskeleton associated protein 5
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CKAP5 protein
CTD
PMID:20109541
NCBI chr 3:80,424,320...80,526,583
Ensembl chr 3:80,468,154...80,526,593
G
Clip1
CAP-GLY domain containing linker protein 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CLIP1 protein
CTD
PMID:20109541
NCBI chr12:38,345,203...38,452,650
Ensembl chr12:38,345,456...38,452,652
G
Coa6
cytochrome c oxidase assembly factor 6
decreases expression
ISO
tetrahydropalmatine results in decreased expression of COA6 protein
CTD
PMID:20109541
NCBI chr19:59,327,328...59,333,706
Ensembl chr19:59,328,960...59,331,192
G
Coasy
Coenzyme A synthase
decreases expression
ISO
tetrahydropalmatine results in decreased expression of COASY protein
CTD
PMID:20109541
NCBI chr10:88,992,413...88,996,677
Ensembl chr10:88,992,487...88,996,676
G
Cops2
COP9 signalosome subunit 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of COPS2 protein
CTD
PMID:20109541
NCBI chr 3:118,109,394...118,137,125
Ensembl chr 3:118,109,406...118,137,191
G
Cops3
COP9 signalosome subunit 3
decreases expression
ISO
tetrahydropalmatine results in decreased expression of COPS3 protein
CTD
PMID:20109541
NCBI chr10:46,182,680...46,206,083
Ensembl chr10:46,182,687...46,206,135
G
Cox6c
cytochrome c oxidase subunit 6C
increases expression
ISO
tetrahydropalmatine results in increased expression of COX6C protein
CTD
PMID:20109541
NCBI chr 7:74,723,177...74,735,650
Ensembl chr 7:74,723,179...74,735,650
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CPT1A protein
CTD
PMID:20109541
NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
G
Crip2
cysteine-rich protein 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CRIP2 protein
CTD
PMID:20109541
NCBI chr 6:137,953,545...137,958,491
Ensembl chr 6:137,953,545...137,958,490
G
Cryz
crystallin zeta
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CRYZ protein
CTD
PMID:20109541
NCBI chr 2:260,884,315...260,911,827
Ensembl chr 2:260,884,337...260,911,792
G
Csde1
cold shock domain containing E1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CSDE1 protein
CTD
PMID:20109541
NCBI chr 2:205,525,194...205,552,987
Ensembl chr 2:205,525,204...205,552,991
G
Cstb
cystatin B
increases expression
ISO
tetrahydropalmatine results in increased expression of CSTB protein
CTD
PMID:20109541
NCBI chr20:10,966,357...10,968,399
Ensembl chr20:10,966,331...10,968,432
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of CYP1A2 mRNA; tetrahydropalmatine results in decreased expression of CYP1A2 protein
CTD
PMID:28257954
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Dcaf7
DDB1 and CUL4 associated factor 7
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DCAF7 protein
CTD
PMID:20109541
NCBI chr10:94,231,585...94,254,046
Ensembl chr10:94,231,585...94,254,046
G
Dctn2
dynactin subunit 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DCTN2 protein
CTD
PMID:20109541
NCBI chr 7:70,555,953...70,571,433
Ensembl chr 7:70,556,019...70,572,614
G
Ddx19b
DEAD-box helicase 19B
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DDX19B protein
CTD
PMID:20109541
NCBI chr19:43,217,199...43,246,196
Ensembl chr19:43,217,161...43,275,287
G
Ddx50
DExD-box helicase 50
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DDX50 protein
CTD
PMID:20109541
NCBI chr20:32,239,736...32,269,522
Ensembl chr20:32,239,748...32,269,145
G
Decr2
2,4-dienoyl-CoA reductase 2
increases expression
ISO
tetrahydropalmatine results in increased expression of DECR2 protein
CTD
PMID:20109541
NCBI chr10:15,451,850...15,460,227
Ensembl chr10:15,431,638...15,465,413
G
Dhx8
DEAH-box helicase 8
increases expression
ISO
tetrahydropalmatine results in increased expression of DHX8 protein
CTD
PMID:20109541
NCBI chr10:89,645,979...89,683,839
Ensembl chr10:89,645,973...89,683,446
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DNAJB11 protein
CTD
PMID:20109541
NCBI chr11:81,741,342...81,757,806
Ensembl chr11:81,741,297...81,757,813
G
Dpp3
dipeptidylpeptidase 3
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DPP3 protein
CTD
PMID:20109541
NCBI chr 1:220,166,124...220,189,762
Ensembl chr 1:220,166,127...220,188,541
G
Drd1
dopamine receptor D1
multiple interactions
ISO
tetrahydropalmatine binds to and results in decreased activity of DRD1 protein
CTD
PMID:17361394
NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
G
Drd2
dopamine receptor D2
multiple interactions
ISO
tetrahydropalmatine binds to and results in decreased activity of DRD2 protein
CTD
PMID:17361394
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
G
Drd3
dopamine receptor D3
affects binding
EXP
tetrahydropalmatine binds to DRD3 protein
CTD
PMID:17361394
NCBI chr11:61,819,102...61,883,223
Ensembl chr11:61,822,077...61,874,327
G
Dync1i2
dynein cytoplasmic 1 intermediate chain 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DYNC1I2 protein
CTD
PMID:20109541
NCBI chr 3:57,817,677...57,868,854
Ensembl chr 3:57,817,693...57,868,854
G
Dync1li2
dynein, cytoplasmic 1 light intermediate chain 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of DYNC1LI2 protein
CTD
PMID:20109541
NCBI chr19:740,007...762,897
Ensembl chr19:740,028...762,897
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
increases expression
ISO
tetrahydropalmatine results in increased expression of EEF1A1 protein
CTD
PMID:20109541
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of EEF1A2 protein
CTD
PMID:20109541
NCBI chr 3:176,657,104...176,666,282
Ensembl chr 3:176,657,107...176,666,282
G
Eif1
eukaryotic translation initiation factor 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of EIF1 protein
CTD
PMID:20109541
NCBI chr10:88,227,455...88,229,546
Ensembl chr10:88,227,360...88,229,765
G
Eif4a2
eukaryotic translation initiation factor 4A2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of EIF4A2 protein
CTD
PMID:20109541
NCBI chr11:81,373,047...81,379,680
Ensembl chr11:81,373,048...81,379,871
G
Exoc8
exocyst complex component 8
decreases expression
ISO
tetrahydropalmatine results in decreased expression of EXOC8 protein
CTD
PMID:20109541
NCBI chr19:57,647,305...57,649,794
Ensembl chr19:57,647,291...57,649,827
G
Faf2
Fas associated factor family member 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of FAF2 protein
CTD
PMID:20109541
NCBI chr17:10,485,650...10,527,886
Ensembl chr17:10,485,642...10,527,864
G
Fah
fumarylacetoacetate hydrolase
decreases expression
ISO
tetrahydropalmatine results in decreased expression of FAH protein
CTD
PMID:20109541
NCBI chr 1:146,713,663...146,736,339
Ensembl chr 1:146,713,676...146,736,261
G
Fam136a
family with sequence similarity 136, member A
decreases expression
ISO
tetrahydropalmatine results in decreased expression of FAM136A protein
CTD
PMID:20109541
NCBI chr 4:118,160,147...118,166,062
Ensembl chr 4:118,160,147...118,166,062
G
Fkbp8
FKBP prolyl isomerase 8
decreases expression
ISO
tetrahydropalmatine results in decreased expression of FKBP8 protein
CTD
PMID:20109541
NCBI chr16:20,645,956...20,652,890
Ensembl chr16:20,645,957...20,652,889
G
Flywch2
FLYWCH family member 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of FLYWCH2 protein
CTD
PMID:20109541
G
Fmr1
FMRP translational regulator 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of FMR1 protein
CTD
PMID:20109541
NCBI chr X:154,684,924...154,722,369
Ensembl chr X:154,684,935...154,722,314
G
Galk1
galactokinase 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of GALK1 protein
CTD
PMID:20109541
NCBI chr10:104,560,322...104,564,499
Ensembl chr10:104,560,303...104,564,480
G
Ganab
glucosidase II alpha subunit
decreases expression
ISO
tetrahydropalmatine results in decreased expression of GANAB protein
CTD
PMID:20109541
NCBI chr 1:225,096,558...225,116,384
Ensembl chr 1:225,096,598...225,116,378
G
Ggh
gamma-glutamyl hydrolase
increases expression
ISO
tetrahydropalmatine results in increased expression of GGH protein
CTD
PMID:20109541
NCBI chr 5:34,040,258...34,063,369
Ensembl chr 5:34,040,258...34,063,361
G
Glrx
glutaredoxin
decreases expression
ISO
tetrahydropalmatine results in decreased expression of GLRX protein
CTD
PMID:20109541
NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
G
Gmppb
GDP-mannose pyrophosphorylase B
increases expression
ISO
tetrahydropalmatine results in increased expression of GMPPB protein
CTD
PMID:20109541
NCBI chr 8:116,826,251...116,856,159
Ensembl chr 8:116,826,680...116,856,159
G
Gpx4
glutathione peroxidase 4
decreases expression
ISO
tetrahydropalmatine results in decreased expression of GPX4 protein
CTD
PMID:20109541
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
G
Gsn
gelsolin
decreases expression
ISO
tetrahydropalmatine results in decreased expression of GSN protein
CTD
PMID:20109541
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
G
Gtpbp4
GTP binding protein 4
decreases expression
ISO
tetrahydropalmatine results in decreased expression of GTPBP4 protein
CTD
PMID:20109541
NCBI chr17:63,111,086...63,145,618
Ensembl chr17:63,110,254...63,145,577
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
increases expression
ISO
tetrahydropalmatine results in increased expression of HIBCH protein
CTD
PMID:20109541
NCBI chr 9:53,446,185...53,526,727
Ensembl chr 9:53,446,194...53,526,728
G
Hint2
histidine triad nucleotide binding protein 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of HINT2 protein
CTD
PMID:20109541
NCBI chr 5:59,150,344...59,152,599
Ensembl chr 5:59,150,345...59,152,599
G
Hk1
hexokinase 1
decreases expression increases expression
ISO
tetrahydropalmatine results in decreased expression of HK1 protein tetrahydropalmatine results in increased expression of HK1 protein
CTD
PMID:20109541
NCBI chr20:31,911,460...31,979,780
Ensembl chr20:31,912,262...31,956,649
G
Hmga1
high mobility group AT-hook 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of HMGA1 protein
CTD
PMID:20109541
NCBI chr20:7,132,501...7,140,155
Ensembl chr20:7,136,007...7,138,980
G
Hmox1
heme oxygenase 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of HMOX1 protein
CTD
PMID:20109541
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hnrnpul2
heterogeneous nuclear ribonucleoprotein U-like 2
increases expression
ISO
tetrahydropalmatine results in increased expression of HNRNPUL2 protein
CTD
PMID:20109541
NCBI chr 1:225,015,722...225,027,640
Ensembl chr 1:225,015,616...225,027,710
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
decreases expression
ISO
tetrahydropalmatine results in decreased expression of IGF2BP3 protein
CTD
PMID:20109541
NCBI chr 4:78,744,683...78,879,457
Ensembl chr 4:78,746,547...78,879,294
G
Ipo9
importin 9
decreases expression
ISO
tetrahydropalmatine results in decreased expression of IPO9 protein
CTD
PMID:20109541
NCBI chr13:52,203,384...52,256,196
Ensembl chr13:52,207,435...52,256,196
G
Iqgap3
IQ motif containing GTPase activating protein 3
decreases expression
ISO
tetrahydropalmatine results in decreased expression of IQGAP3 protein
CTD
PMID:20109541
NCBI chr 2:187,447,477...187,489,630
Ensembl chr 2:187,447,501...187,489,630
G
Jpt2
Jupiter microtubule associated homolog 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of JPT2 protein
CTD
PMID:20109541
NCBI chr10:14,304,108...14,324,170
Ensembl chr10:14,304,104...14,324,211
G
Letm1
leucine zipper and EF-hand containing transmembrane protein 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of LETM1 protein
CTD
PMID:20109541
NCBI chr14:82,227,790...82,267,298
Ensembl chr14:82,227,708...82,267,350
G
Lta4h
leukotriene A4 hydrolase
decreases expression
ISO
tetrahydropalmatine results in decreased expression of LTA4H protein
CTD
PMID:20109541
NCBI chr 7:34,288,333...34,320,243
Ensembl chr 7:34,288,365...34,320,235
G
Mak16
MAK16 homolog
decreases expression
ISO
tetrahydropalmatine results in decreased expression of MAK16 protein
CTD
PMID:20109541
NCBI chr16:64,729,254...64,737,807
Ensembl chr16:64,729,221...64,737,807
G
Man1b1
mannosidase, alpha, class 1B, member 1
increases expression
ISO
tetrahydropalmatine results in increased expression of MAN1B1 protein
CTD
PMID:20109541
NCBI chr 3:2,547,259...2,569,051
Ensembl chr 3:2,547,986...2,569,049
G
Map1b
microtubule-associated protein 1B
increases expression
ISO
tetrahydropalmatine results in increased expression of MAP1B protein
CTD
PMID:20109541
NCBI chr 2:29,675,391...29,768,750
Ensembl chr 2:29,675,391...29,768,750
G
Map2k2
mitogen activated protein kinase kinase 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of MAP2K2 protein
CTD
PMID:20109541
NCBI chr 7:11,458,971...11,478,520
Ensembl chr 7:11,458,967...11,478,489
G
Metap2
methionyl aminopeptidase 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of METAP2 protein
CTD
PMID:20109541
NCBI chr 7:34,762,241...34,789,456
Ensembl chr 7:34,762,231...34,789,479
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
tetrahydropalmatine results in decreased expression of MTOR protein
CTD
PMID:20109541
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
G
Ncaph
non-SMC condensin I complex, subunit H
increases expression
ISO
tetrahydropalmatine results in increased expression of NCAPH protein
CTD
PMID:20109541
NCBI chr 3:119,583,798...119,611,148
Ensembl chr 3:119,583,648...119,611,136
G
Nceh1
neutral cholesterol ester hydrolase 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of NCEH1 protein
CTD
PMID:20109541
NCBI chr 2:112,868,834...112,932,622
Ensembl chr 2:112,868,707...112,934,953
G
Ndufb5
NADH:ubiquinone oxidoreductase subunit B5
decreases expression
ISO
tetrahydropalmatine results in decreased expression of NDUFB5 protein
CTD
PMID:20109541
NCBI chr 2:119,139,717...119,153,753
Ensembl chr 2:119,139,717...119,153,753
G
Nelfe
negative elongation factor complex member E
decreases expression
ISO
tetrahydropalmatine results in decreased expression of NELFE protein
CTD
PMID:20109541
NCBI chr20:4,530,328...4,536,085
Ensembl chr20:4,530,342...4,536,209
G
Nfu1
NFU1 iron-sulfur cluster scaffold
decreases expression
ISO
tetrahydropalmatine results in decreased expression of NFU1 protein
CTD
PMID:20109541
NCBI chr 4:118,814,284...118,834,955
Ensembl chr 4:118,814,284...118,834,955
G
Nipsnap1
nipsnap homolog 1
increases expression
ISO
tetrahydropalmatine results in increased expression of NIPSNAP1 protein
CTD
PMID:20109541
NCBI chr14:85,113,578...85,137,457
Ensembl chr14:85,113,578...85,137,454
G
Nubp2
nucleotide binding protein 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of NUBP2 protein
CTD
PMID:20109541
NCBI chr10:14,244,201...14,247,930
Ensembl chr10:14,244,203...14,247,886
G
Nufip2
nuclear FMR1 interacting protein 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of NUFIP2 protein
CTD
PMID:20109541
NCBI chr10:65,168,145...65,200,210
Ensembl chr10:65,176,648...65,200,109
G
Nup155
nucleoporin 155
decreases expression
ISO
tetrahydropalmatine results in decreased expression of NUP155 protein
CTD
PMID:20109541
NCBI chr 2:57,206,665...57,258,242
Ensembl chr 2:57,206,613...57,258,295
G
Palld
palladin, cytoskeletal associated protein
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PALLD protein
CTD
PMID:20109541
NCBI chr16:31,865,712...31,948,168
G
Pawr
pro-apoptotic WT1 regulator
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PAWR protein
CTD
PMID:20109541
NCBI chr 7:51,273,764...51,353,700
Ensembl chr 7:51,273,771...51,353,068
G
Pds5a
PDS5 cohesin associated factor A
increases expression
ISO
tetrahydropalmatine results in increased expression of PDS5A protein
CTD
PMID:20109541
NCBI chr14:44,185,445...44,282,308
Ensembl chr14:44,185,446...44,280,079
G
Picalm
phosphatidylinositol binding clathrin assembly protein
increases expression
ISO
tetrahydropalmatine results in increased expression of PICALM protein
CTD
PMID:20109541
NCBI chr 1:154,377,229...154,458,966
Ensembl chr 1:154,377,247...154,458,425
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PIN1 protein
CTD
PMID:20109541
NCBI chr 8:21,669,236...21,680,615
Ensembl chr 8:21,669,236...21,680,615
G
Ppil3
peptidylprolyl isomerase like 3
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PPIL3 protein
CTD
PMID:20109541
NCBI chr 9:65,315,407...65,329,145
Ensembl chr 9:65,315,410...65,329,066
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PPP2CB protein
CTD
PMID:20109541
NCBI chr16:62,273,276...62,294,767
Ensembl chr16:62,273,276...62,294,769
G
Praf2
PRA1 domain family, member 2
increases expression
ISO
tetrahydropalmatine results in increased expression of PRAF2 protein
CTD
PMID:20109541
NCBI chr X:15,618,324...15,620,992
Ensembl chr X:15,618,991...15,620,841
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PRKAR1A protein
CTD
PMID:20109541
NCBI chr10:97,940,705...97,959,199
Ensembl chr10:97,940,705...97,957,336
G
Prkca
protein kinase C, alpha
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PRKCA protein
CTD
PMID:20109541
NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
G
Prpf4
pre-mRNA processing factor 4
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PRPF4 protein
CTD
PMID:20109541
NCBI chr 5:78,267,248...78,281,172
Ensembl chr 5:78,267,248...78,281,172
G
Prpsap1
phosphoribosyl pyrophosphate synthetase-associated protein 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PRPSAP1 protein
CTD
PMID:20109541
NCBI chr10:105,430,516...105,492,154
Ensembl chr10:105,430,520...105,452,228
G
Pym1
PYM homolog 1, exon junction complex associated factor
decreases expression
ISO
tetrahydropalmatine results in decreased expression of PYM1 protein
CTD
PMID:20109541
NCBI chr 7:3,172,798...3,193,994
Ensembl chr 7:3,173,287...3,193,994
G
Rab3gap1
RAB3 GTPase activating protein catalytic subunit 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of RAB3GAP1 protein
CTD
PMID:20109541
NCBI chr13:44,578,208...44,649,876
Ensembl chr13:44,615,553...44,648,620
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
increases expression
ISO
tetrahydropalmatine results in increased expression of RAF1 protein
CTD
PMID:20109541
NCBI chr 4:147,532,040...147,592,769
Ensembl chr 4:147,532,042...147,592,699
G
Ranbp2
RAN binding protein 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of RANBP2 protein
CTD
PMID:20109541
NCBI chr20:28,027,054...28,076,664 NCBI chr20:28,365,538...28,375,676
Ensembl chr20:28,027,054...28,076,664 Ensembl chr20:28,027,054...28,076,664
G
Rbm39
RNA binding motif protein 39
decreases expression increases expression
ISO
tetrahydropalmatine results in decreased expression of RBM39 protein tetrahydropalmatine results in increased expression of RBM39 protein
CTD
PMID:20109541
NCBI chr 3:151,691,498...151,724,723
Ensembl chr 3:151,691,514...151,724,654 Ensembl chr 3:151,691,514...151,724,654
G
Reep5
receptor accessory protein 5
decreases expression
ISO
tetrahydropalmatine results in decreased expression of REEP5 protein
CTD
PMID:20109541
NCBI chr18:27,128,462...27,159,693
Ensembl chr18:27,128,464...27,159,693
G
Rfc4
replication factor C subunit 4
increases expression
ISO
tetrahydropalmatine results in increased expression of RFC4 protein
CTD
PMID:20109541
NCBI chr11:81,358,592...81,373,044
Ensembl chr11:81,358,592...81,373,043
G
Rhob
ras homolog family member B
decreases expression
ISO
tetrahydropalmatine results in decreased expression of RHOB protein
CTD
PMID:20109541
NCBI chr 6:33,689,127...33,691,301
Ensembl chr 6:33,689,127...33,691,301
G
Rmnd5a
required for meiotic nuclear division 5 homolog A
increases expression
ISO
tetrahydropalmatine results in increased expression of RMND5A protein
CTD
PMID:20109541
NCBI chr 4:99,249,159...99,305,805
Ensembl chr 4:99,253,633...99,305,812
G
Rnf40
ring finger protein 40
decreases expression
ISO
tetrahydropalmatine results in decreased expression of RNF40 protein
CTD
PMID:20109541
NCBI chr 1:199,037,472...199,052,823
Ensembl chr 1:199,037,544...199,052,172
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of ROCK2 protein
CTD
PMID:20109541
NCBI chr 6:42,180,864...42,289,910
Ensembl chr 6:42,180,894...42,289,908
G
Rpa2
replication protein A2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of RPA2 protein
CTD
PMID:20109541
NCBI chr 5:150,957,041...150,967,597
Ensembl chr 5:150,957,001...150,968,269
G
Rps28
ribosomal protein S28
decreases expression
ISO
tetrahydropalmatine results in decreased expression of RPS28 protein
CTD
PMID:20109541
NCBI chr 7:18,682,071...18,683,440
Ensembl chr 7:18,682,071...18,683,440
G
Rps6ka3
ribosomal protein S6 kinase A3
increases expression
ISO
tetrahydropalmatine results in increased expression of RPS6KA3 protein
CTD
PMID:20109541
NCBI chr X:37,469,736...37,576,055
Ensembl chr X:37,469,937...37,575,624
G
Septin11
septin 11
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SEPTIN11 protein
CTD
PMID:20109541
NCBI chr14:16,369,544...16,405,645
Ensembl chr14:16,369,544...16,452,998
G
Slc22a1
solute carrier family 22 member 1
multiple interactions
ISO
tetrahydropalmatine inhibits the reaction [SLC22A1 protein results in increased uptake of Monocrotaline]; tetrahydropalmatine inhibits the reaction [SLC22A1 protein results in increased uptake of retrorsine]
CTD
PMID:23831208 PMID:24799337
NCBI chr 1:48,273,639...48,300,645
Ensembl chr 1:48,273,611...48,300,655
G
Slc25a10
solute carrier family 25 member 10
increases expression
ISO
tetrahydropalmatine results in increased expression of SLC25A10 protein
CTD
PMID:20109541
NCBI chr10:109,665,682...109,674,782
Ensembl chr10:109,665,682...109,673,143
G
Smarca5
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SMARCA5 protein
CTD
PMID:20109541
NCBI chr19:30,936,703...30,969,454
Ensembl chr19:30,936,703...30,969,454
G
Sms
spermine synthase
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SMS protein
CTD
PMID:20109541
NCBI chr X:40,363,646...40,415,110
Ensembl chr X:40,363,646...40,415,109
G
Sncg
synuclein, gamma
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SNCG protein
CTD
PMID:20109541
NCBI chr16:10,722,110...10,726,648
Ensembl chr16:10,722,106...10,726,707
G
Snrpe
small nuclear ribonucleoprotein polypeptide E
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SNRPE protein
CTD
PMID:20109541
NCBI chr13:50,252,707...50,258,951
Ensembl chr 8:129,371,556...129,371,973
G
Snw1
SNW domain containing 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SNW1 protein
CTD
PMID:20109541
NCBI chr 6:111,483,698...111,507,782
Ensembl chr 6:111,483,703...111,507,782
G
Snx1
sorting nexin 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SNX1 protein
CTD
PMID:20109541
NCBI chr 8:71,745,687...71,786,182
Ensembl chr 8:71,745,896...71,784,551
G
Snx2
sorting nexin 2
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SNX2 protein
CTD
PMID:20109541
NCBI chr18:48,132,386...48,173,974
Ensembl chr18:48,132,414...48,173,971
G
Spdl1
spindle apparatus coiled-coil protein 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SPDL1 protein
CTD
PMID:20109541
NCBI chr10:19,628,070...19,652,914
Ensembl chr10:19,628,258...19,652,898
G
Sri
sorcin
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SRI protein
CTD
PMID:20109541
NCBI chr 4:23,004,657...23,029,233
Ensembl chr 4:23,006,243...23,018,983
G
Srp19
signal recognition particle 19
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SRP19 protein
CTD
PMID:20109541
NCBI chr18:27,114,822...27,121,062
Ensembl chr18:27,114,822...27,121,059
G
Srp68
signal recognition particle 68
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SRP68 protein
CTD
PMID:20109541
NCBI chr10:105,123,324...105,150,080
Ensembl chr10:105,123,327...105,228,547
G
Srpra
SRP receptor subunit alpha
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SRPRA protein
CTD
PMID:20109541
NCBI chr 8:36,410,683...36,416,766
Ensembl chr 8:36,410,683...36,416,296
G
Stat1
signal transducer and activator of transcription 1
increases expression
ISO
tetrahydropalmatine results in increased expression of STAT1 protein
CTD
PMID:20109541
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
G
Stxbp1
syntaxin binding protein 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of STXBP1 protein
CTD
PMID:20109541
NCBI chr 3:11,823,779...11,885,479
Ensembl chr 3:11,823,785...11,885,417
G
Swap70
switching B-cell complex subunit SWAP70
increases expression
ISO
tetrahydropalmatine results in increased expression of SWAP70 protein
CTD
PMID:20109541
NCBI chr 1:174,862,683...174,924,101
Ensembl chr 1:174,862,698...174,924,078
G
Syvn1
synoviolin 1
decreases expression
ISO
tetrahydropalmatine results in decreased expression of SYVN1 protein
CTD
PMID:20109541
NCBI chr 1:221,409,281...221,416,229
Ensembl chr 1:221,409,271...221,417,886
G
Tma7
translation machinery associated 7 homolog
decreases expression
ISO
tetrahydropalmatine results in decreased expression of TMA7 protein
CTD
PMID:20109541
NCBI chr 8:117,815,725...117,820,422
Ensembl chr 8:117,815,725...117,820,413
G
Tmed4
transmembrane p24 trafficking protein 4
decreases expression
ISO
tetrahydropalmatine results in decreased expression of TMED4 protein
CTD
PMID:20109541
NCBI chr14:86,390,327...86,395,151
Ensembl chr14:86,390,338...86,395,135
G
Top1
DNA topoisomerase I
increases expression
ISO
tetrahydropalmatine results in increased expression of TOP1 protein
CTD
PMID:20109541
NCBI chr 3:156,635,688...156,717,686
Ensembl chr 3:156,642,464...156,717,686
G
Tsnax
translin-associated factor X
decreases expression
ISO
tetrahydropalmatine results in decreased expression of TSNAX protein
CTD
PMID:20109541
NCBI chr19:57,771,539...57,785,567
Ensembl chr19:57,771,398...57,785,543
G
Tsr2
TSR2, ribosome maturation factor
increases expression
ISO
tetrahydropalmatine results in increased expression of TSR2 protein
CTD
PMID:20109541
NCBI chr X:20,141,406...20,146,082
Ensembl chr X:20,144,432...20,232,639
G
Ttc37
tetratricopeptide repeat domain 37
decreases expression
ISO
tetrahydropalmatine results in decreased expression of TTC37 protein
CTD
PMID:20109541
NCBI chr 2:2,891,265...3,037,602
Ensembl chr 2:2,903,492...3,004,553
G
Uap1
UDP-N-acetylglucosamine pyrophosphorylase 1
increases expression
ISO
tetrahydropalmatine results in increased expression of UAP1 protein
CTD
PMID:20109541
NCBI chr13:88,463,532...88,497,901
Ensembl chr13:88,463,532...88,497,901
G
Vps45
vacuolar protein sorting 45 homolog
increases expression
ISO
tetrahydropalmatine results in increased expression of VPS45 protein
CTD
PMID:20109541
NCBI chr 2:198,123,747...198,184,739
Ensembl chr 2:198,123,748...198,184,739
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
increases expression
ISO
tetrahydropalmatine results in increased expression of WDHD1 protein
CTD
PMID:20109541
NCBI chr15:24,021,674...24,056,073
Ensembl chr15:24,021,674...24,056,073
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all